American Society of Hirudotherapy

Cervical Radiculopathy

Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
No — investigated off-label. The FDA cleared medicinal leeches in 2004 only for venous congestion in microsurgical reconstruction (K040187). Use for cervical radiculopathy is investigational, with no verifiable published trial, and is not FDA-evaluated.
What evidence exists?
No published trial of leech therapy for cervical radiculopathy was identified. A previously cited randomized trial could not be verified for this indication, and its citation was removed. Older Russian reports of leech therapy for spinal radiculopathy, summarized in a 2004 monograph, gave no neck-specific results. The proposed rationale is extrapolated from leech studies in other musculoskeletal pain conditions and remains speculative. Leech therapy is not appropriate when there is progressive weakness, severe nerve compression on imaging, or any sign of spinal cord involvement — those require urgent surgical evaluation.
Main risks
  • Bleeding and oozing from bite sites on the neck and shoulder for several hours
  • Bruising along the neck for 3 to 7 days, which can be cosmetically noticeable
  • Itching, redness, and irritation at bite sites for days to weeks
  • Small permanent scars on the neck or upper back
  • Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
  • Allergic reaction to leech saliva (uncommon)
  • Temporary worsening of pain or stiffness for 1 to 2 days after the session
Who should not consider this
  • Patients taking blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
  • Patients with hemophilia or other inherited bleeding disorders
  • Patients with anemia
  • Patients with a weakened immune system
  • Patients with progressive arm weakness, hand clumsiness, or balance problems (surgical evaluation needed)
  • Patients with spinal cord compression on imaging (urgent surgical evaluation)
  • Patients with any sign of infection near the spine
What to ask your clinician
  • Have I had an MRI, and is there a structural problem that needs surgical evaluation first?
  • Am I a candidate for standard treatments — physical therapy, NSAIDs, epidural steroid injection — and have I given them a fair trial?
  • What is the realistic chance leech therapy will help me, and for how long?
  • What is the practitioner's experience with cervical-region leech application?
  • What antibiotic plan do you use for Aeromonas prevention?
  • What red flags should I and my family watch for after the session?
  • What is the cost, and is it covered by insurance? (typically not)
When to seek urgent care
  • New or worsening weakness in the arm or hand
  • New numbness, tingling, or weakness in the legs, balance problems, or loss of bladder/bowel control (possible spinal cord involvement — emergency)
  • Sudden severe neck pain with fever and stiff neck (possible spinal infection)
  • Bleeding from a bite site lasting more than 24 hours
  • Spreading redness, warmth, pus, or red streaks (cellulitis)
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty

What this does NOT mean

  • It does not mean leech therapy is FDA-cleared for cervical radiculopathy — it is not.
  • It does not mean leech therapy fixes the underlying disc or bone problem — it may only reduce symptoms temporarily.
  • It does not mean it replaces neurosurgical evaluation when there are red-flag features such as progressive weakness or spinal cord signs.
  • It does not mean every patient improves — with no verifiable published trial for this indication, individual responses cannot be predicted.
  • It does not mean improvement is permanent — no long-term outcome data for this indication were identified.

Clinical Profile

Category
Neurological
ICD-10
M50.10, M50.11, M50.12, M50.13, M54.12
Safety tier
Medium

Evidence Summary

No randomized controlled trial or neck-specific clinical study of leech therapy for cervical radiculopathy was identified in PubMed, Europe PMC or Crossref. Russian clinical series of vertebrogenic radiculopathy summarized in the Baskova and Isakhanyan 2004 monograph (for example Konyrtaeva and Tulesarinov 1999, 280 patients with disc herniation or protrusion; Arutyunov 1998, 37 patients; Mokhov and Zaltsman 1998, 8 patients with cervicothoracic or lumbosacral radicular syndrome) give no separate cervical result. A proposed rationale, extrapolated from leech trials in other musculoskeletal pain syndromes, combines local anti-inflammatory effects with reduction of paravertebral venous congestion that may contribute to nerve-root edema, but this remains speculative. Use is investigational and is not a substitute for surgical evaluation in patients with progressive motor deficit.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Baskova and Isakhanyan do not write separately about radicular (nerve-root) pain in the neck and arm specifically: they describe vertebrogenic radiculopathies in general and conclude that hirudotherapy “is indicated and widely used” for them; the cervicothoracic level is named only as part of a group of patients with radicular syndrome of the cervicothoracic and lumbosacral regions[B1].
  • Baskova and Isakhanyan write that in vertebrogenic radiculopathies, with age and the development of degenerative changes, the size of the “tunnel” through which the nerve root exits decreases, circulation in the zone of compression is impaired and swelling develops, and leeches are prescribed to improve local circulation and lymph flow and to reduce swelling and pain[B1].
  • The report by Mokhov and Zaltsman (1998) involved 8 patients with radicular syndrome of cervicothoracic and lumbosacral location; in 5 the authors described a marked effect in the form of practical regression, in 3 complete compensation could not be achieved; the results are not separated by level in the retelling[B1].
  • In the section on cervical syndrome and cervicobrachialgia, Michalsen et al. call hirudotherapy an excellent treatment alternative in patients with muscle hypertonia (increased muscle tension) and pain radiating from the shoulder (brachial) region; whether this refers to radicular pain is not clear from the text[B3].
  • For vertebrogenic (spine-related) pain syndromes in general, Michalsen et al. call hirudotherapy an excellent alternative, especially when the physical examination reveals painful hardening of muscles and connective tissue next to the spine, and write that it often relieves such pain immediately and thereby improves the conditions for physical therapy and kinesitherapy, which are also required[B3].
  • Neither Baskova and Isakhanyan nor Michalsen et al. discuss which manifestations of pain in the neck and arm require emergency care, so this question cannot be settled from these books, and neither book says that leeches can replace an examination by a physician.
  • Both books list hemophilia, anemia and concurrent use of anticoagulants among the contraindications (this is only part of their lists); Flecken and Michalsen add that aspirin or clopidogrel are not in themselves considered a contraindication, but in that case the number of leeches is reduced at the first session[B1][B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Progressive motor deficit (surgical referral)
  • Spinal cord compression on imaging
  • Active epidural infection

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.